Idexx Laboratories (IDXX) announced the availability of the Idexx Cancer Dx Panel in the United Kingdom, beginning with early detection of lymphoma in at-risk dogs.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- Idexx Laboratories price target lowered to $675 from $775 at Stifel
- Idexx Laboratories management to meet with Piper Sandler
- Idexx Laboratories Announces Executive Departure Amid Strategic Realignment
- Top Hedge Fund Manager Sounds the Alarm on Market Risk. Here Are 4 Ways to Play a Possible Selloff
- TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI